(0.24%) 5 112.12 points
(0.19%) 38 314 points
(0.25%) 15 968 points
(-1.38%) $82.69
(3.69%) $1.994
(0.09%) $2 349.40
(-0.10%) $27.51
(3.54%) $954.70
(-0.19%) $0.933
(-0.32%) $10.99
(-0.42%) $0.797
(1.49%) $93.24
Live Chart Being Loaded With Signals
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chronic renal failure; Gemcit for non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin for infertility and annovulation; Growtropin II for growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel for breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone for use in functional dyspepsia treatment; Stillen for the treatment of gastritis; Suganon for diabetes treatment; Terizidone for active pulmonary and extra-pulmonary tuberculosis; and Zydena for erectile dysfunction treatment...
Stats | |
---|---|
今日成交量 | 31 499.00 |
平均成交量 | 51 440.00 |
市值 | 581.87B |
EPS | KRW0 ( 2024-04-28 ) |
下一个收益日期 | ( KRW1 085.00 ) 2024-07-25 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW164.68 (0.24%) |
音量 相关性
Dong-A ST Co., Ltd. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Dong-A ST Co., Ltd. 相关性 - 货币/商品
Dong-A ST Co., Ltd. 财务报表
Annual | 2023 |
营收: | KRW663.98B |
毛利润: | KRW322.21B (48.53 %) |
EPS: | KRW1 284.83 |
FY | 2023 |
营收: | KRW663.98B |
毛利润: | KRW322.21B (48.53 %) |
EPS: | KRW1 284.83 |
FY | 2022 |
营收: | KRW635.39B |
毛利润: | KRW315.39B (49.64 %) |
EPS: | KRW1 543.95 |
FY | 2021 |
营收: | KRW593.23B |
毛利润: | KRW293.88B (49.54 %) |
EPS: | KRW122.18 |
Financial Reports:
No articles found.
Dong-A ST Co., Ltd.
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chronic renal failure; Gemcit for non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin for infertility and annovulation; Growtropin II for growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel for breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone for use in functional dyspepsia treatment; Stillen for the treatment of gastritis; Suganon for diabetes treatment; Terizidone for active pulmonary and extra-pulmonary tuberculosis; and Zydena for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high technology medical devices, custom made products, and sets of artificial cardiac circuits for use in open-heart surgery. Dong-A ST Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。